BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31537869)

  • 1.
    Zhang C; Zhang Z; Merkens H; Zeisler J; Colpo N; Hundal-Jabal N; Perrin DM; Lin KS; Bénard F
    Sci Rep; 2019 Sep; 9(1):13575. PubMed ID: 31537869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma Imaging Using
    Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
    Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET of malignant melanoma using 18F-labeled metallopeptides.
    Ren G; Liu Z; Miao Z; Liu H; Subbarayan M; Chin FT; Zhang L; Gambhir SS; Cheng Z
    J Nucl Med; 2009 Nov; 50(11):1865-72. PubMed ID: 19837749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Melanoma Imaging with
    Zhang C; Zhang Z; Lin KS; Pan J; Dude I; Hundal-Jabal N; Colpo N; Bénard F
    Theranostics; 2017; 7(4):805-813. PubMed ID: 28382155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
    Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
    J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
    Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
    Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1.
    Ren G; Liu S; Liu H; Miao Z; Cheng Z
    Bioconjug Chem; 2010 Dec; 21(12):2355-60. PubMed ID: 21073170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
    Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
    J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Al
    Palangka CRAP; Hanaoka H; Yamaguchi A; Murakami T; Tsushima Y
    Ann Nucl Med; 2019 Oct; 33(10):733-739. PubMed ID: 31297699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
    Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
    Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.
    Wei L; Zhang X; Gallazzi F; Miao Y; Jin X; Brechbiel MW; Xu H; Clifford T; Welch MJ; Lewis JS; Quinn TP
    Nucl Med Biol; 2009 May; 36(4):345-54. PubMed ID: 19423001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor.
    Zhang C; Lin KS; Bénard F
    Mol Imaging; 2017; 16():1536012117737919. PubMed ID: 29182034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Al
    Qiao Z; Xu J; Gonzalez R; Miao Y
    Bioconjug Chem; 2022 May; 33(5):982-990. PubMed ID: 35475603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel
    Qiao Z; Xu J; Gonzalez R; Miao Y
    Mol Pharm; 2022 Jul; 19(7):2535-2541. PubMed ID: 35486894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylated DOTA-alpha-melanocyte-stimulating hormone analogues for melanoma targeting: influence of the site of glycosylation on in vivo biodistribution.
    Bapst JP; Calame M; Tanner H; Eberle AN
    Bioconjug Chem; 2009 May; 20(5):984-93. PubMed ID: 19388674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Metal-Free DOTA-Conjugated
    Roxin Á; Zhang C; Huh S; Lepage M; Zhang Z; Lin KS; Bénard F; Perrin DM
    Bioconjug Chem; 2019 Apr; 30(4):1210-1219. PubMed ID: 30896929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.
    Miao Y; Figueroa SD; Fisher DR; Moore HA; Testa RF; Hoffman TJ; Quinn TP
    J Nucl Med; 2008 May; 49(5):823-9. PubMed ID: 18413404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors.
    Cantorias MV; Figueroa SD; Quinn TP; Lever JR; Hoffman TJ; Watkinson LD; Carmack TL; Cutler CS
    Nucl Med Biol; 2009 Jul; 36(5):505-13. PubMed ID: 19520291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocortin-1 receptor-targeting with radiolabeled cyclic α-melanocyte-stimulating hormone analogs for melanoma imaging.
    Raposinho PD; Correia JD; Oliveira MC; Santos I
    Biopolymers; 2010; 94(6):820-9. PubMed ID: 20564045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-trifluoroborate derivatives of [des-arg(10)]kallidin for imaging bradykinin b1 receptor expression with positron emission tomography.
    Liu Z; Amouroux G; Zhang Z; Pan J; Hundal-Jabal N; Colpo N; Lau J; Perrin DM; Bénard F; Lin KS
    Mol Pharm; 2015 Mar; 12(3):974-82. PubMed ID: 25629412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.